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Sources of Faculty Inventions
• Colleague referrals to the Technology Transfer  
Office
• Publications
• Abstracts posted at a conference
• Industry sponsored research
• Conference presentations
• Grant submissions
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Technology Commercialization 
Process
• Disclosure of invention
• Initial evaluation and market research
• Patentability Search
• Commercialization strategy
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• File patent/copyright/trademark
• Potential enhancement of technology
• Material Transfer/Research Agreements
• Out licensing or Company spin-off
Formal disclosure of the invention to KUCTC ……..
KUCTC will consider expediting the patenting process, which may 
involve the filing of a Provisional Patent Application. Copyright and 
trademark protection will also be considered as appropriate. 
Does a company have 
rights to the invention 
under an MTA or 
research agreement? 
For life science inventions, the IAMI will determine if they wish to 
include the invention in their Project Pipeline. If IAMI chooses not to 
include the invention in their Project Pipeline, KUCTC staff will contact 
companies that might be interested in licensing the invention.  If 
appropriate, KUCTC will discuss start-up opportunities with faculty 
and/or students who have expressed such an interest.
Is a public 
disclosure 
scheduled?
Special note: A informal pre-invention disclosure discussion 
may also be scheduled. The  Institute for Advancing Medical 
Innovation (IAMI) staff participates in all life science invention 
disclosure meetings
Yes
No
No
A Typical KUCTC Invention Management Process
Is the company 
interested in the 
invention?
If there is no start-up opportunity and no existing companies are 
interested in the invention, KUCTC will evaluate the market potential 
for the invention.  KUCTC may decide to either (a) apply for patent 
protection despite the lack of interest if KUCTC believes the 
technology to have substantial future commercial value (b) continue to 
evaluate the invention in the future to determine if further development 
work might enhance the commercial value of the invention or (c) return 
the invention to the Inventor(s).  
Is the company 
ready to license 
the invention or 
take an option?
KUCTC will pursue an option agreement or Letter 
of Intent with the company.
Yes
No
Yes
No.  They need more time 
to evaluate the invention.
KUCTC will negotiate a license agreement for the invention.  The agreement will include but not limited to upfront 
fees or equity in the case of a start-up company, annual maintenance fees, milestone fees (clinical trials), 
diligence terms with performance milestones, and the payment of patent costs.  
Technology Assessment
• Occurs at the time of –
» Invention disclosure
» Patent conversion
» USPTO Office Actions
» PCT filings
» Before returning to inventor
• Deal structures
• To secure potential licensees
• By whom-
» IAMI Board
» KU Alumni
» KU administration and faculty
» Regional and national entrepreneurs and executives
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Marketing
• Faculty/Staff member is often a good resource
• Database searches, associations lists, conventions, 
publications and personal networking 
• Non-confidential disclosures
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• Confidential disclosures
• Corporate Partner for licensing and/or additional funding
University Patent Budgets
• How is the Tech Transfer Office funded?
• Expectations for the office, i.e., self-sustaining?
• Current status of licensing revenues, i.e. big  hit or  
soon to expire patent
• Status of technology pipeline
• Does the TT office have an endowment?
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Patent Expenses
• Cover Sheet Provisional Patent Application-
~ $1K
• Full Provisional Patent Application- ~ $4 K
• NonProvisional Patent Application- ~ $11 K
• PCT Patent Filing- ~ $5 K
• National Phase Patent Filing- ~ $5-10 K per country
• Office  Actions- Variable cosst
• Restrictions (Divisionals)- results in a new patent
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Patent Application Timing
• File Patent Application before public disclosure to preserve 
foreign rights
• Convert Provisional Patent Application to a NonProvisional 
Patent Application within 12 months of its filing
• File Patent Cooperation Treaty (PCT) 12 months from the 
first patent filing
• Patent will be published online 18 months from filing
• Select foreign countries 30 months from the first patent 
filing
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Within Universities Kansas Start-Up Commercialization Entity
National Drug Development Accelerator
Integration with Technology Transfer 
• Invention disclosure and patent activities integrated into drug project team 
activities managed by IAMI Project directors
» Technical evaluation of invention disclosure
» Go/no go decision points tied to patent investments
» “Pharma” profiling of intellectual property
» Seed funding decisions based on ROI
» Industry approach to laboratory documentation, central repository 
for data, standard format for commercial product summaries
• KUCTC full members on project teams, Target Prioritization Committee, 
and to-be-formed Pipeline Prioritization Committee
• Patent research to map IP landscape and guide or direct focused areas of 
research
• Move technology out of KU and into the hands of organizations who have 
the resources to advance technologies and products
KU Center for 
Technology Commercialization
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